Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Effect of Radiofrequency in the Treatment of de Novo Dyspareunia at 4 to 12 Months Postpartum.

NCT: NCT05417334 · COMPLETED

NCT IDNCT05417334
StatusCOMPLETED
Start Date2021-03-18
Completion2024-06-21
SponsorHospital Clinic of Barcelona (OTHER)
First posted
Last updated

Brief Summary

This study evaluates if the application of resistive capacitive monopolar radiofrequency therapy associated with Thiele massage is effective when treating de novo dyspareunia at 4 to 12 months postpartum.

Frequently Asked Questions

What is Effect of Radiofrequency in the Treatment of de Novo Dyspareunia at 4 to 12 Months Postpartum.?

Effect of Radiofrequency in the Treatment of de Novo Dyspareunia at 4 to 12 Months Postpartum. is a clinical trial registered under NCT05417334. Current status: COMPLETED.

What is the status of NCT05417334?

The current status of NCT05417334 (Effect of Radiofrequency in the Treatment of de Novo Dyspareunia at 4 to 12 Months Postpartum.) is: COMPLETED.

When did Effect of Radiofrequency in the Treatment of de Novo Dyspareunia at 4 to 12 Months Postpartum. start?

Effect of Radiofrequency in the Treatment of de Novo Dyspareunia at 4 to 12 Months Postpartum. started on 2021-03-18.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑